Corrigendum to “Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism” [Diabetes Metab. 41 (2015) 331–337] - 03/12/16

M. de Kerdanet ^{a, ⁎} , M. Caron-Debarle ^{b, c, d}, S. Nivot ^a, T. Gaillot ^a, O. Lascols ^{b, c, d}, B. Fremont ^e, M. Bonnaure-Mallet ^a, S. Gie ^a, C. Massart ^f, J. Capeau ^{b, c, d}

^a Pediatric Endocrinology Unit, University Hospital, Rennes, France 

^b INSERM, UMR-S 938, CDR Saint-Antoine, 75012 Paris, France 

^c Sorbonne University UPMC Université Paris 06, UMR-S 938, 75012 Paris, France 

^d Institute of Cardiometabolism and Nutrition (ICAN), AP–HP, GH HUEP, 75012 Paris, France 

^e Pediatric Surgery Service, University Hospital, Rennes, France 

^f Laboratory of Molecular Genetic and Hormonology, University Hospital, Rennes, France 

^⁎Corresponding author at: Unité d’endocrinologie pédiatrique, Hôpital Sud, 16, boulevard de Bulgarie, 35056 Rennes Cedex, France. Tel.: +33 2 99 26 71 36; fax: +33 2 99 26 67 02.Unité d’endocrinologie pédiatrique, Hôpital Sud16, boulevard de BulgarieRennes Cedex35056France

Le texte complet de cet article est disponible en PDF.